Zusammenfassung
Ziel: Die Verminderung des peripheren Gefäßwiderstands in der Schwangerschaft wird durch eine NO-getriggerte Gefäßdilatation vermittelt. Diese physiologische Änderung der Endothelfunktion während des Schwangerschaftsverlaufs und im Wochenbett wurde mittels der noninvasiven Erfassung der flussabhängigen Gefäßdilatation durch hochauflösende Ultraschallmessung ermittelt. Material und Methoden: In einer prospektiven Beobachtungsstudie wurde longitudinal an 16 schwangeren Frauen im 1. Trimenon (T1) < 14. Schwangerschaftswochen (SSW), 2. Trimenon (T2) ≥ 14. – 27. SSW, 3. Trimenon (T3) ≥ 28. SSW und > 6 Wochen postpartal (pp) sonografisch die FMD der A. brachialis ermittelt. 19 nicht schwangere Frauen (NS) wurden als Vergleichsgruppe in die Studie eingeschlossen. Ergebnisse: Die FMD (%) stieg vom 1. zum 2. Trimenon (T1 8,0 ± 5,58 vs. T 2 15,2 ± 5,19, p < 0,003) signifikant an und erreichte ihr Maximum in der Mitte der Schwangerschaft. Zum 3. Trimenon fiel die FMD wieder signifikant ab (T2 vs. T 3 9,15 ± 3,61, p < 0,004). Die Mittelwerte der FMD waren im 2. und 3. Trimenon verglichen mit den nicht schwangeren Kontrollen signifikant erhöht (T2 vs. NS 6,17 ± 4,39, p < 0,0001; T 3 vs. NS, p < 0,047). Postpartal fiel die FMD auf das Niveau der in der Frühschwangerschaft bestimmten Werte zurück. Schlussfolgerung: Im Schwangerschaftsverlauf ändert sich die maternale Endothelfunktion mit einer Zunahme der flussabhängigen Gefäßerweiterung, die im Wochenbett wieder verschwindet. Mittels der FMD-Messung lassen sich diese physiologischen Veränderungen im Schwangerschaftsverlauf zuverlässig erfassen.
Abstract
Purpose: NO-triggered vasodilatation decreases peripheral vascular resistance in pregnancy. Using a noninvasive ultrasound technique, flow-mediated vasodilatation can be quantified. We used this technique to detect changes in endothelial function during pregnancy and postpartum. Materials and Methods: In a prospective longitudinal study 16 healthy pregnant women were assessed for flow-mediated dilatation of the brachial artery during pregnancy (first trimester T 1 < 14th gestational week, second trimester T 2 ≥ 14th – 27th gestational week, third trimester T 3 ≥ 28th gestational week) and postpartum (> 6 weeks postpartum). As a control group, flow-mediated dilatation was determined in 19 healthy non-pregnant women. Results: Flow-mediated dilatation (%) increased significantly in normal human pregnancy from the first trimester (T1 8.0 ± 5.58 vs. T 2 15.2 ± 5.19, p < 0.003) to the second trimester and reached its maximum in mid-trimester. Towards the end of pregnancy, flow-mediated dilatation decreased significantly (T2 vs. T 3 9.15 ± 3.61, p < 0.004). Mean values of flow-mediated dilatation are significantly higher during the second and third trimester of pregnancy compared to non-pregnant controls (T2 vs. NP 6.17 ± 4.39, p < 0.001; T 3 vs. NP, p < 0.047). Postpartum flow-mediated dilatation decreased to values of early pregnancy. Conclusion: During pregnancy maternal endothelial function shows an increase in flow-mediated dilatation and then reverts postpartum. Using ultrasound-based measurement of flow-mediated dilatation, these physiological changes in pregnancy can be reliably detected.
Key words
endothelial function - pregnancy - flow-mediated dilatation
Literatur
1
Williams D J, Vallance P J, Neild G H et al.
Nitric oxide-mediated vasodilation in human pregnancy.
Am J Physiol.
1997;
272
H748-H752
2
MacGillivray I, Rose G A, Rowe B.
Blood pressure survey in pregnancy.
Clin Sci.
1969;
37
395-407
3
Atkins A F, Watt J M, Milan P et al.
A longitudinal study of cardiovascular dynamic changes throughout pregnancy.
Eur J Obstet Gynecol Reprod Biol.
1981;
12
215-224
4
Page E W, Christianson R.
The impact of mean arterial pressure in the middle trimester upon the outcome of pregnancy.
Am J Obstet Gynecol.
1976;
125
740-746
5
Furchgott R F, Zawadzki J V.
The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine.
Nature.
1980;
288
373-376
6
Pohl U, Holtz J, Busse R et al.
Crucial role of endothelium in the vasodilator response to increased flow in vivo.
Hypertension.
1986;
8
37-44
7
Nabel E G, Selwyn A P, Ganz P.
Large coronary arteries in humans are responsive to changing blood flow: an endothelium-dependent mechanism that fails in patients with atherosclerosis.
J Am Coll Cardiol.
1990;
16
349-356
8
Ludmer P L, Selwyn A P, Shook T L et al.
Paradoxical vasoconstriction induced by acetylcholine in atherosclerotic coronary arteries.
N Engl J Med.
1986;
315
1046-1051
9
Calver A, Collier J, Green D et al.
Effect of acute plasma volume expansion on peripheral arteriolar tone in healthy subjects.
Clin Sci.
1992;
83
541-547
10
Jäger K A, Staub D.
Haben Sie die Intima-Media-Dicke gemessen?.
Ultraschall in Med.
2009;
30
434-437
11
Schreuder F H, Graf M, Hameleers J M et al.
Measurement of Common Carotid Artery Intima-Media Thickness in Clinical Practice: Comparison of B-Mode and RF-Based Technique.
Ultraschall in Med.
2009;
30
459-465
12
Celermajer D S, Sorensen K E, Gooch V M et al.
Non-invasive detection of endothelial dysfunction in children and adults at risk of atherosclerosis.
Lancet.
1992;
340
1111-1115
13
Accini J L, Sotomayor A, Trujillo F et al.
Colombian study to assess the use of noninvasive determination of endothelium-mediated vasodilatation (CANDEV). Normal values and factors associated.
Endothelium.
2001;
8
157-166
14
Corretti M C, Anderson T J, Benjamin E J et al.
Guidelines for the ultrasound assessment of endothelial-dependent flow-mediated vasodilation of the brachial artery: a report of the International Brachial Artery Reactivity Task Force.
J Am Coll Cardiol.
2002;
39
257-265
15
Balletshofer B M, Goebbel S, Rittig K et al.
Influence of experience on intra- and interindividual variability in assessing peripheral endothelial dysfunction with high resolution ultrasound.
Ultraschall in Med.
2001;
22
231-235
16
Christianson R E.
Studies on blood pressure during pregnancy. I. Influence of parity and age.
Am J Obstet Gynecol.
1976;
125
509-513
17
Meredith I T, Currie K E, Anderson T J et al.
Postischemic vasodilation in human forearm is dependent on endothelium-derived nitric oxide.
Am J Physiol.
1996;
270
H1435-H1440
18
Dørup I, Skajaa K, Sørensen K E.
Normal pregnancy is associated with enhanced endothelium-dependent flow-mediated vasodilation.
Am J Physiol.
1999;
276
H821-H825
19
Faber-Swensson A P, O’Callaghan S P, Walters W A.
Endothelial cell function enhancement in a late normal human pregnancy.
Aust N Z J Obstet Gynaecol.
2004;
44
525-529
20
Quinton A E, Cook C M, Peek M J.
A longitudinal study using ultrasound to assess flow-mediated dilatation in normal human pregnancy.
Hypertens Pregnancy.
2007;
26
273-281
21
Noori M, Donald A E, Angelakopoulou A et al.
Prospective study of placental angiogenic factors and maternal vascular function before and after preeclampsia and gestational hypertension.
Circulation.
2010;
122
478-487
22
Savvidou M D, Kametas N A, Donald A E et al.
Non-invasive assessment of endothelial function in normal pregnancy.
Ultrasound Obstet Gynecol.
2000;
15
502-507
23
Hunter S, Robson S C.
Adaptation of the maternal heart in pregnancy.
Br Heart J.
1992;
68
540-543
24
Pyke K E, Tschakovsky M E.
The relationship between shear stress and flow-mediated dilatation: implications for the assessment of endothelial function.
J Physiol.
2005;
568
357-369
25
Cooke J P, Stamler J, Andon N et al.
Flow stimulates endothelial cells to release a nitrovasodilator that is potentiated by reduced thiol.
Am J Physiol.
1990;
259
H804-H812
26
Joannides R, Haefeli W E, Linder L et al.
Nitric oxide is responsible for flow-dependent dilatation of human peripheral conduit arteries in vivo.
Circulation.
1995;
91
1314-1319
27
Palmer R M, Ashton D S, Moncada S.
Vascular endothelial cells synthesize nitric oxide from L-arginine.
Nature.
1988;
333
664-666
28
Collins P, Griffith T M, Henderson A H et al.
Endothelium-derived relaxing factor alters calcium fluxes in rabbit aorta: a cyclic guanosine monophosphate-mediated effect.
J Physiol.
1986;
381
427-437
29
Arnold W P, Mittal C K, Katsuki S et al.
Nitric oxide activates guanylate cyclase and increases guanosine 3’:5’-cyclic monophosphate levels in various tissue preparations.
Proc Natl Acad Sci U S A.
1977;
74
3203-3207
30
Vallance P, Collier J, Moncada S.
Effects of endothelium-derived nitric oxide on peripheral arteriolar tone in man.
Lancet.
1989;
2
997-1000
31
Ramsay B, Sooranna S R, Johnson M R.
Nitric oxide synthase activities in human myometrium and villous trophoblast throughout pregnancy.
Obstet Gynecol.
1996;
87
249-253
32
Sladek S M, Magness R R, Conrad K P.
Nitric oxide and pregnancy.
Am J Physiol.
1997;
272
R441-R463
33
Boccardo P, Soregaroli M, Aiello S et al.
Systemic and fetal-maternal nitric oxide synthesis in normal pregnancy and pre-eclampsia.
Br J Obstet Gynaecol.
1996;
103
879-886
34
Telfer J F, Itoh H, Thomson A J et al.
Activity and expression of soluble and particulate guanylate cyclases in myometrium from nonpregnant and pregnant women: down-regulation of soluble guanylate cyclase at term.
J Clin Endocrinol Metab.
2001;
86
5934-5943
35
Celermajer D S, Sorensen K E, Bull C et al.
Endothelium-dependent dilation in the systemic arteries of asymptomatic subjects relates to coronary risk factors and their interaction.
J Am Coll Cardiol.
1994;
24
1468-1474
36
Schiessl B, Kainer F, Oberhoffer R et al.
Doppler sonography of the uterine and the cubital arteries in normal pregnancies, preeclampsia and intrauterine growth restriction: evidence for a systemic vessel involvement.
J Perinat Med.
2006;
34
139-144
37
Adali E, Kurdoglu M, Adali F et al.
The relationship between brachial artery flow-mediated dilatation, high sensitivity C-reactive protein, and uterine artery doppler velocimetry in women with pre-eclampsia.
J Clin Ultrasound.
2010;
. [Epub ahead of print]
38
Filho E V, Mohr C, Filho B J et al.
Flow-mediated dilatation in the differential diagnosis of preeclampsia syndrome.
Arq Bras Cardiol.
2010;
94
182-186, 195 – 200, 185 – 189
39
Matsubara K, Matsubara Y, Hyodo S et al.
Role of nitric oxide and reactive oxygen species in the pathogenesis of preeclampsia.
J Obstet Gynaecol Res.
2010;
36
239-247
40
Savvidou M D, Noori M, Anderson J M et al.
Maternal endothelial function and serum concentrations of placental growth factor and soluble endoglin in women with abnormal placentation.
Ultrasound Obstet Gynecol.
2008;
32
871-876
Christin Seeliger
Abteilung Geburtshilfe, Universitätsfrauenklinik
Bachstraße 18
07743 Jena
Phone: ++ 49/(0)1 51 58 01 96 89
Fax: ++ 49/36 41 93 39 86
Email: christin.seeliger@med.uni-jena.de